Future drug development and Lecanemab's indirect effects on Alzheimer's disease.

Published Date: 20 Jul 2023

The transition of lecanemab to traditional approval and how this choice will affect future care for Alzheimer's disease were discussed by David Bates, PhD, chief executive officer and co-founder of Linus Health.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Does pollution cause cancer?

2.

AI is equally capable of reading breast cancer scans as human radiologists.

3.

EVP Beats Cisplatin for Resectable MIBC

4.

New research points out a promising strategy for treating metastatic medulloblastoma

5.

Academics + Pharma = Big Bucks; New CAR-T Warnings; Patients Seek Cancer Tests.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot